Orchid Pharma enter tech transfer pact to make key cephalosporin intermediate
Chennai-based drug maker, Orchid Pharma, has signed a technology transfer agreement with a multinational biotechnology company, for its 7ACA project under the production linked incentive (PLI) scheme. The deal will enable Orchid Bio Pharma to manufacture "7-ACA" with a capacity of 1,000 tonnes p.a. 7-ACA is the key intermediate for the synthesis of semisynthetic cephalosporin antibiotics.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
